Irritable bowel syndrome: how can symptoms and quality of life be improved with diet?
被引:0
|
作者:
Guerreiro, Margarida
论文数: 0引用数: 0
h-index: 0
机构:
Univ Lisbon, Fac Med, Lisbon, PortugalUniv Lisbon, Fac Med, Lisbon, Portugal
Guerreiro, Margarida
[1
]
Guerreiro, Catarina Sousa
论文数: 0引用数: 0
h-index: 0
机构:
Univ Lisbon, Fac Med, Lisbon, Portugal
Univ Lisbon, Lab Nutr, Lisbon, Portugal
Univ Lisbon, Inst Saude Ambiental, Fac Med, Lisbon, PortugalUniv Lisbon, Fac Med, Lisbon, Portugal
Guerreiro, Catarina Sousa
[1
,2
,3
]
Cravo, Marilia
论文数: 0引用数: 0
h-index: 0
机构:
Univ Lisbon, Fac Med, Lisbon, Portugal
Hosp Beatriz Angelo, Serv Gastroenterol, Loures, PortugalUniv Lisbon, Fac Med, Lisbon, Portugal
Cravo, Marilia
[1
,4
]
机构:
[1] Univ Lisbon, Fac Med, Lisbon, Portugal
[2] Univ Lisbon, Lab Nutr, Lisbon, Portugal
[3] Univ Lisbon, Inst Saude Ambiental, Fac Med, Lisbon, Portugal
[4] Hosp Beatriz Angelo, Serv Gastroenterol, Loures, Portugal
Purpose of review This article aims to review the current scientific evidence of dietary approaches to control the symptoms of irritable bowel syndrome (IBS). Recent findings In the last decade, there was an important evolution in the study of the low fermentable oligo, di, mono-saccharides and polyols (FODMAP) diet (LFD). Current scientific evidence suggests a significant efficacy in the overall control of symptoms. LFD seems to be effective in improving quality of life. Recent studies suggest that LFD is effective and nutritionally well tolerated also in the long term, and longer adherence may contribute to greater effectiveness in improving depression. There is insufficient scientific evidence for the recommendation of gluten exclusion in IBS therapy, and some authors still suggest that the efficacy of this approach results from the limited ingestion of fructans. There is a promising efficacy of pre, pro, and symbiotic supplements, but there is no consensus on the most appropriate and effective strains in each case. Given the poor evidence and the pathophysiological variability of IBS, the interest of each therapeutic option should be always evaluated individually. Nevertheless, LFD is currently the dietary approach with a higher degree of scientific evidence.
机构:
Boston Univ, Sect Gastroenterol, Sch Med, 650 Albany St,EBRC,Room 810, Boston, MA 02118 USA
VA Boston Healthcare Syst, Sect Gastroenterol & Hepatol, Boston, MA USABoston Univ, Sect Gastroenterol, Sch Med, 650 Albany St,EBRC,Room 810, Boston, MA 02118 USA
机构:
Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Clin Med A Murri, Sch Med, I-70124 Bari, ItalyUniv Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Clin Med A Murri, Sch Med, I-70124 Bari, Italy
Portincasa, Piero
论文数: 引用数:
h-index:
机构:
Bonfrate, Leonilde
de Bari, Ornella
论文数: 0引用数: 0
h-index: 0
机构:
Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Clin Med A Murri, Sch Med, I-70124 Bari, ItalyUniv Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Clin Med A Murri, Sch Med, I-70124 Bari, Italy
de Bari, Ornella
Lembo, Anthony
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Med Sch, Dept Med & Gastroenterol, Beth Israel Deaconess Med Ctr, Boston, MA USAUniv Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Clin Med A Murri, Sch Med, I-70124 Bari, Italy
Lembo, Anthony
Ballou, Sarah
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Med Sch, Dept Med & Gastroenterol, Beth Israel Deaconess Med Ctr, Boston, MA USAUniv Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Clin Med A Murri, Sch Med, I-70124 Bari, Italy